Telisotuzumab usage, dosage and medication precautions

Telisotuzumab (Telisotuzumab) is a targeted therapy drug that belongs to the antibody conjugate drug (ADC) category and is mainly used to treat c-Met-positive non-small cell lung cancer (NSCLC). As a new generation of precision targeted therapy drugs, terituzumab recognizes c-Met receptors on the surface of tumor cells, carries cytotoxins into cancer cells, and exerts a killing effect, thereby effectively inhibiting tumor growth and metastasis. This article will introduce in detail the usage, dosage and medication precautions of territuzumab to help patients and clinicians use the drug rationally.

1. Usage and dosage

Territuzumab is usually given as an intravenous infusion. The recommended dose is 1.9 mg/kg per cycle, usually every 3 weeks (21 days). The specific medication cycle and frequency must be determined by the doctor based on the patient's specific condition, tumor type and treatment response. Administration should be infused slowly, generally lasting no less than 30 minutes, to reduce the risk of infusion-related reactions.

In the early stages of treatment, patients need to be closely monitored, and doctors will adjust the dosage or extend the dosage interval in a timely manner based on the patient's tolerance and tumor response. If serious adverse reactions occur, the drug may need to be temporarily discontinued or treatment reduced, and the specific plan should be determined by a professional physician.

2. Precautions when taking medication

1.Allergic reaction:

During intravenous infusion, patients may experience allergic reactions or infusion-related reactions, such as fever, chills, rash, difficulty breathing, etc. When the above symptoms occur, the infusion should be stopped immediately, anti-allergic treatment should be given, and whether to continue taking the medication should be decided according to the condition.

2.Liver function monitoring:

Terituzumab may affect liver function. It is recommended to regularly monitor liver function indicators, such as transaminase, bilirubin, etc. during treatment. If abnormalities are found, the doctor should be reported in time and the treatment plan should be adjusted if necessary.

3. Blood system reaction:

Hematological adverse reactions such as thrombocytopenia and leukopenia may occur during treatment. Patients should undergo regular blood routine examinations to prevent the risk of infection and bleeding.

4.Other adverse reactions:

May include fatigue, nausea, vomiting, loss of appetite, etc. Patients should maintain good living habits, eat reasonably, and report physical discomfort to the doctor in a timely manner.

3. Medication for Special Populations

1. Elderly patients and those with liver and kidney dysfunction should use it with caution and adjust the dose if necessary.

2.Contraindicated for pregnant and lactating women to avoid potential effects on fetuses and infants.

3.Patients with a history of severe cardiopulmonary disease should use it after risk assessment under the guidance of a doctor.

4. Drug interactions

There is currently no clear evidence that terituzumab has significant interactions with other drugs, but patients should inform their attending physician when taking other drugs (including Chinese herbal medicines and health products) to avoid potential risks.

5. Suggestions on patient medication management

Patients should strictly follow the doctor's instructions for infusion, and have regular follow-up visits and relevant examinations to ensure safe and effective treatment. If you experience any discomfort, you should contact your doctor promptly to avoid delaying treatment. During home care, attention should be paid to keeping the infusion site clean to prevent infection.

Territuzumab, as a precision targeted therapy, has shown good efficacy in c-Met positive non-small cell lung cancer. Reasonable usage and dosage and careful medication precautions are the keys to ensuring successful treatment. Patients and doctors should cooperate closely, strictly abide by medication specifications, pay attention to adverse reactions, adjust treatment plans in a timely manner, and maximize the therapeutic value of drugs.

Reference materials:https://www.drugs.com/